Grant✓ Small businesses may apply
DoW Rare Cancers Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Program funding
$7,350,000
- Opportunity #
- HT942526RCRPIDA
- Agency
- Defense Health Agency Contracting Activity - DHACA
- ALN (CFDA)
- 12.420
- Status
- posted
- Posted
- Jun 17, 2026
- Closes
- Nov 18, 2026
- Funding instrument
- Grant
- Category
- Science and Technology and other Research and Development
- Cost sharing required
- No
Who can apply
- •Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Synopsis
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
- The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
- Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
- Research should have high potential impact on rare cancers and the patient community.
Contact
JoAnn Martin Grantor · help@eBRAP.org